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Summary
Malaria remains a public health problem of enormous
magnitude, affecting over 500 million people every
year. Lack of success in the past in the development
of new drug/vaccines has mainly been attributed to
poor understanding of the functions of different par-
asite proteins. Recently, RNA interference (RNAi) has
emerged as a simple and incisive technique to study
gene functions in a variety of organisms. In this study,
we report the results of RNAi by double-stranded RNA
of cysteine protease genes (
 
falcipain
 
-1 and -2) in the
malaria parasite, 
 
Plasmodium falciparum
 
. Using RNAi
directed towards falcipain genes, we demonstrate
that blocking the expression of these genes results
in severe morphological abnormalities in parasites,
inhibition of parasite growth 
 
in vitro
 
 and substantial
accumulation of haemoglobin in the parasite. The
inhibitory effects produced by falcipain double-
stranded (ds)RNAs are reminiscent of the effects
observed upon administering E-64, a cysteine pro-
tease inhibitor. The parasites treated with falcipain’s
dsRNAs also show marked reduction in the levels of
corresponding endogenous 
 
falcipain
 
 mRNAs. We
also demonstrate that dsRNAs of falcipains are
broken into short interference RNAs 
 
≈
 
 25 nucleotides
in size, a characteristic of RNAi, which in turn acti-
vates sequence-specific nuclease activity in the
malaria parasites. These results thus provide more
evidence for the existence of RNAi in 
 
P. falciparum
 
and also suggest possibilities for using RNAi as an
effective tool to determine the functions of the genes
identified from the 
 
P. falciparum
 
 genome sequencing
project.
Introduction
 
In the fight against malaria, there is an urgent need to
develop new antimalarials and an effective vaccine
because of widespread resistance to common antimalar-
ials (Ridley, 2002). The progress in the development of
effective antimalarials/vaccine has been slow because of
a poor understanding of the functions of different parasite
proteins (Cowman 
 
et al
 
., 2000). One of the direct ways to
determine the biological function of a protein is to examine
the phenotype of the organism that contains mutations in
the coding gene or to knock out the gene by homologous
recombination. In recent years, methodologies have been
developed that permit transfection of 
 
Plasmodium falci-
parum
 
, 
 
Plasmodium berghei
 
 and 
 
Plasmodium knowlesi
 
,
as well as the deletion of specific parasite genes in order
to study their function (Waters 
 
et al
 
., 1997). However,
malaria transfection studies, together with previously
employed biochemical approaches, have provided limited
insight into our understanding of the molecular basis of
parasite infection (Cowman 
 
et al
 
., 2000). With the comple-
tion of the malaria genome project, there is an urgent
need for additional methods for assessing gene functions
in the malaria parasite.
Recently, RNA interference (RNAi) has emerged as a
powerful method for studying gene functions in a wide
range of organisms, both unicellular organisms such
as 
 
Trypanosoma brucei
 
 and 
 
Plasmodium falciparum
 
(Ngo 
 
et al
 
., 1998; McRobert and McConkey, 2002) and
multicellular organisms such as 
 
Caenorhabditis elegans
 
,
 
Drosophila
 
, 
 
Planaria
 
, 
 
Hydra
 
, zebrafish and mouse
(Cogoni and Maino, 2000). The term RNAi refers to the
sequence-specific degradation of mRNA by its homolo-
gous double-stranded (ds)RNA (Fire, 1999). Although
RNAi was first demonstrated in nematodes (Fire 
 
et al
 
.,
1998), similar phenomena, called post-transcriptional
gene silencing (PTGS) in plants (Baulcombe, 1999) and
‘quelling’ in fungi (Cogoni 
 
et al
 
., 1996), have been known
for many years. Recently, RNAi was applied successfully
to study the functions of a large number of genes on a
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genomic scale in 
 
C. elegans
 
 (Fraser 
 
et al
 
., 2000; Gonczy
 
et al
 
., 2000; Maeda 
 
et al
 
., 2001).
Given the fact that gene knock-out experiments in 
 
P.
falciparum
 
 are difficult to carry out and RNAi has been
used to study gene functions in variety of organisms
(Zamore 
 
et al
 
., 2000), we explored the possibility of using
this technique in 
 
P. falciparum.
 
 We used dsRNAs of the
two cysteine protease genes of 
 
P. falciparum
 
 to evaluate
their metabolic roles in the erythrocytic stages of the par-
asite. Degradation of haemoglobin is a prerequisite for the
establishment and multiplication of the parasite. A series
of experiments on haemoglobin degradation pathways in
 
P. falciparum
 
 led to the identification of three cysteine
proteases (also known as falcipain 1, falcipain 2 and fal-
cipain 3), 10 aspartic proteases (called plasmepsins) and
metalloproteases involved in haemoglobin degradation
(Coombs 
 
et al
 
., 2001; Eggleson 
 
et al
 
., 1999; Sijwali 
 
et al
 
.,
2001). However, the exact roles of these 
 
Plasmodium
 
proteases in the haemoglobin degradation pathway are
not clearly understood. To understand the precise roles of
falcipains in the haemoglobin degradation pathway, we
carried out silencing of two 
 
falcipain
 
 genes by their
respective dsRNAs. These experiments revealed that the
treatment of parasites by 
 
falcipain
 
-1 and -2 dsRNAs not
only results in marked reduction in the levels of cognate
cellular messenger RNA but also brings about several
morphological and biochemical changes, which are rem-
iniscent of changes induced by other specific inhibitors of
cysteine proteases. Detailed analysis of the mode of RNAi
action revealed that these effects are mediated by the
formation of an 
 
≈
 
 25 nucleotide (nt) RNA species, a fea-
ture characteristic of all PTGS phenomena. These results
have important implications for carrying out large-scale
functional genomic studies in 
 
P. falciparum.
 
Results
 
RNAi functions in
 
 P. falciparum
The hallmarks of RNAi are its specificity, simplicity and
the ease by which RNAi can be applied to an organism.
RNAi has been induced in most organisms by microinjec-
tions (Fjose 
 
et al
 
., 2001). However, in 
 
C. elegans
 
, large-
scale gene silencing by RNAi was carried out successfully
simply by soaking worms in dsRNA containing solution
or by feeding worms with 
 
Escherichia coli
 
 that express
dsRNA (Maeda 
 
et al
 
., 2001). In 
 
Drosophila
 
 S2 cell lines,
RNAi was used for dissecting signal transduction path-
ways just by adding dsRNA to the culture medium
(Clemens 
 
et al
 
., 2000). Based on these observations, we
decided to study RNAi in 
 
P. falciparum
 
 by adding dsRNAs
to the culture medium using the protocol described by
Clemens 
 
et al
 
. (2000). We have successfully carried out
gene silencing of aminopeptidase-N gene in 
 
Spodoptera
frugiperda
 
 21 (Sf21) cell lines using the same protocol
(unpublished results). All the dsRNAs used in the present
study were analysed on 1% agarose gel to make sure that
these were predominantly double stranded (Fig. 1B). As
 
P. falciparum
 
 is an intracellular parasite, at the beginning
of our analysis of RNAi, we studied the uptake of 
 
32
 
P-
labelled dsRNAs of 
 
falcipains
 
 by malaria parasites. To do
this, synchronized 
 
P. falciparum
 
 cultures were incubated
with 10 nM 
 
32
 
P-labelled dsRNA from either of the 
 
falci-
pains.
 
 After 24 h of incubation, parasitized erythrocytes
were collected by centrifugation, lysed with saponin and
washed three times to obtain a pure parasite pellet. Levels
of radioactivity were measured in different fractions of
parasitized red blood cells (RBCs). Approximately 0.1–
0.15% of the input labelled dsRNAs were found to be
associated with the purified parasite pellets, suggesting
that dsRNAs were taken up by the parasite. This result
was in line with the earlier observations by Rapaport 
 
et al
 
.
(1992), who showed uptake of labelled oligodeoxynucle-
otides by 
 
P. falciparum
 
-infected erythrocytes. Uptake of
antisense oligodeoxynucleotides (ODNs) from the culture
medium and their inhibitory effects have also been
reported in 
 
P. falciparum
 
 (Barker 
 
et al
 
., 1996).
To determine the effects of 
 
falcipain
 
 dsRNAs on 
 
P. fal-
ciparum
 
, synchronized parasites at late ring stages were
 
Fig. 1.
 
 A. Schematic representation of the two 
 
falcipain
 
 genes of 
 
P. 
falciparum
 
 used to produce single-strand RNA and dsRNA 
 
in vitro
 
 
(SS, signal sequence; Pro, pro region; T7/SP6, promoter sequences).
B. Agarose gel electrophoresis of ssRNAs and dsRNAs of falcipain-
1 and -2. To prepare dsRNA, antisense RNAs (asRNAs) and sense 
RNAs (ssRNAs) were synthesized using T7 and SP6 polymerases. 
ssRNA and asRNA from each of the 
 
falcipains
 
 were mixed, incubated 
at 65
 
°
 
C and cooled slowly to obtain their corresponding dsRNAs. 
Lane 1, 
 
falcipain
 
-1 dsRNA; lane 2, 
 
falcipain
 
-1 ssRNA; lane 3, 
 
falcipain
 
-1 asRNA; lane 4, 
 
falcipain
 
-2 dsRNA; lane 5, 
 
falcipain
 
-2 
ssRNA; lane 6, 
 
falcipain
 
-2 asRNA.
 Gene silencing in
 
 P. falciparum 1247
 
© 2002 Blackwell Science Ltd, 
 
Molecular Microbiology
 
, 
 
45
 
, 1245–1254
 
incubated with dsRNA for each of the two falcipains
separately, as well as in combination, at three different
concentrations of 10 
 
µ
 
g ml
 
−
 
1
 
, 25 
 
µ
 
g ml
 
−1
 
 and 50 
 
µ
 
g ml
 
−
 
1
 
,
corresponding to approximate final concentrations of
10 nM, 25 nM and 50 nM respectively. Inclusion of dsR-
NAs in the parasite culture caused distinct morphological
changes, the most notable of which was the abnormally
swollen food vacuoles that contained an accumulation of
malaria pigment (Fig. 2A). These effects were similar
to that seen upon incubation of parasites with a well-
established cysteine protease inhibitor, E-64 (Rosenthal,
1995). As shown in Table 1, at a 10 
 
µ
 
g ml
 
−1
 
 concentration
of each of these dsRNAs, morphological effects seen
on the cultured parasites were marginal. However, at
25 
 
µ
 
g ml
 
−
 
1
 
 and 50 
 
µ
 
g ml
 
−1
 
 concentrations of dsRNA of
 
falcipains
 
-1 or -2, up to 30% of parasites developed food
vacuole abnormalities. Significantly, when dsRNAs of both
 
falcipains
 
 were included at the above concentrations,
about 60% of the parasites showed food vacuole abnor-
malities. Addition of the two dsRNAs together to the par-
asite culture also reduced the formation of new rings as
well as total parasitaemia. In contrast, addition of dsRNA
from aminopeptidase-N (50 
 
µ
 
g ml
 
−
 
1
 
) of insect origin, used
as a control in the present study, had no affect on either
parasite morphology or its development.
We confirmed further the inhibitory effects of 
 
falcipain
 
dsRNAs on 
 
P. falciparum
 
 by an assay that uses [
 
3
 
H]-
hypoxanthine uptake as a measure of parasite growth
(Fig. 2B). In this assay, the aminopeptidase-N dsRNA was
used as a negative control, whereas E-64 was used as a
positive control. At a 50 
 
µ
 
g ml
 
−
 
1
 
 concentration of individual
 
falcipain
 
 dsRNA, there was a 25–35% reduction in the
uptake of [
 
3
 
H]-hypoxanthine. However, when the two 
 
fal-
cipain
 
 dsRNAs were combined, the reduction in the
uptake of [
 
3
 
H]-hypoxanthine was enhanced to the level of
 
≈
 
 65%. In comparison, E-64 at 50 
 
µ
 
M concentration al-
most completely inhibited the uptake of [
 
3
 
H]-hypoxanthine,
whereas aminopeptidase-N dsRNA at this concentration
had no effect at all (Fig. 2B). These results were thus
consistent with earlier observations, which showed that
various inhibitors of cysteine proteases affect parasite
metabolism and development.
 
Inhibition of haemoglobin degradation by falcipain 
dsRNAs in 
 
P. falciparum
 
 parasites
 
Cysteine protease activities have mainly been identified
in the extracts of trophozoites, an erythrocytic parasite
stage during which most haemoglobin degradation occurs
and most antimalarial drugs have been shown to act
(Rosenthal, 1995). Various studies using either native fal-
cipains or recombinant falcipains have demonstrated a
central role for the falcipains in the haemoglobin degrada-
tion pathway (Sijwali 
 
et al
 
., 2001). It has been suggested
that morphological abnormalities displayed by malaria
parasites after treatment with different cysteine protease
inhibitors result from inhibition of haemoglobin degrada-
tion (Rosenthal, 1995). To investigate whether the
observed morphological abnormalities in 
 
falcipain
 
 dsRNA-
treated parasites were indeed caused by a blockage in
haemoglobin degradation, parasite cultures were treated
with dsRNA from the two 
 
falcipains
 
, separately or
together, at 50 
 
µ
 
g ml
 
−
 
1
 
 concentration, and the parasite
proteins were subsequently analysed by SDS-PAGE.
Incubation of parasites with dsRNAs for each of the
 
falcipains
 
 caused the accumulation of large quantities
of undegraded haemoglobin in these parasites (Fig. 3A,
lanes 2–4). E-64, a general cysteine protease inhibitor,
was used as a positive control (Fig. 3A, lane 6). In the
control parasite culture containing no inhibitor, a minimum
level of undegraded haemoglobin was observed (Fig. 3A,
lane 1). The block in haemoglobin degradation produced
by each 
 
falcipain
 
 dsRNA indicated that these dsRNAs
were able to effect the functioning of these genes, i.e.
these dsRNAs were able to induce specific gene
silencing.
Table 1. Effects of Falcipain dsRNAs and E-64 on the morphology and viability of cultured parasites.
Treatment Concentration
Food vacuole
abnormalitya
Percentage 
ring parasites
Falcipain-1 dsRNA 10 µg ml−1 (9.0 nM) + 82
25 µg ml−1 (23.0 nM) ++ 60
50 µg ml−1 (45.5 nM) ++ 65
Falcipain-2 dsRNA 10 µg ml−1 (11.0 nM) + 90
25 µg ml−1 (27.0 nM) ++ 70
50 µg ml−1 (50.0 nM) ++ 77
Falcipain-1 and -2 dsRNAs 25 µg ml−1 each +++ 35
50 µg ml−1 each ++++ 30
Control (DEPC water) – – 100
E-64 100 mM ++++++ 0
Aminopeptidase-N (Spodoptera litura) dsRNA 50 µg ml−1 – 99
a. Percent abnormal parasites: −, 0%; +, 10%; ++, 30%; +++, 40%; ++++ , 60%; ++++++, 75%
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Fig. 2. A. Effects of falcipain dsRNA treatment on P. falciparum parasite morphology; note the abnormally swollen food vacuoles with malaria 
pigment in the treated parasites.
B. Inhibition of [3H]-hypoxanthine uptake in cultured parasites by Falcipain dsRNAs. Microwell cultures of ring-stage parasites were incubated 
with Falcipain dsRNAs for 24 h. Approximately 1 µCi of [3H]-hypoxanthine was added to each well, and cultures were maintained for an additional 
24 h. The cells were harvested, and [3H]-hypoxanthine was quantified using a scintillation counter. Aminopeptidase-N (Spodoptera litura) dsRNA 
was used as a control.
Gene silencing in P. falciparum 1249
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Falcipain dsRNAs induce degradation of homologous 
messenger RNA
To determine whether morphological and biochemical
effects induced by falcipain dsRNAs resulted from RNAi,
we examined the fate of falcipain mRNAs in dsRNA-
treated parasite cultures by Northern blot analysis.
Parasites treated with the falcipain-1 dsRNA showed
diminished endogenous falcipain-1 mRNA compared with
the untreated, falcipain-2 and aminopeptidase-N dsRNA-
treated parasites [Fig. 3B(i)]. Similarly, treatment of para-
sites with falcipain-2 dsRNA caused marked reduction in
falcipain-2 mRNA compared with control parasites,
whereas the level of falcipain-1 mRNA in falcipain-2
dsRNA-treated parasites was comparable with that in
control parasites [Fig. 3B(ii)]. Overall, in falcipain-1 or
falcipain-2 dsRNA-treated parasites, there was a signifi-
cant reduction in the levels of cognate mRNAs compared
with their levels in untreated parasites. These results indi-
cated that inhibitory effects seen in parasite cultures after
treatment with falcipain dsRNAs are caused specifically
by RNAi.
Dissection of the mechanism of RNAi in P. falciparum
A striking paradigm to emerge from the study of RNAi/
PTGS in plants and animals is that gene silencing in these
organisms occurs as a result of the generation of small
RNA called guide RNA or small interfering RNA (siRNA).
A number of publications addressing the mechanism of
RNAi have suggested that, during RNAi, dsRNA breaks
into small guide RNAs, and these small RNAs activate
and get associated with RNase complex that degrades the
target mRNA (Zamore et al., 2000; Elbashir et al., 2001).
To determine whether falcipain dsRNAs are also pro-
cessed into small RNAs in vivo, the cultured parasites
were treated with 32P-labelled dsRNA from either of the
two falcipains used in this study. After 24 h of incubation,
parasite pellets were processed to get total RNAs
and, subsequently, small RNA species were isolated
from the total RNAs. The small RNA species were then
analysed by polyacrylamide gel electrophoresis. As
shown in Fig. 4A, both falcipain dsRNAs were processed
to ≈ 25 nt species. We also observed an additional RNA
species of ≈ 70 nt in the dsRNA-treated parasites. Such
intermediate/longer RNA species have also been
observed in other studies, although their role in RNAi has
not yet been elucidated (Grishok et al., 2001).
With the development of the Drosophila in vitro system,
different steps underlying the mechanism of RNAi have
been recapitulated in vitro (Zamore et al., 2000; Elbashir
et al., 2001). In the in vitro system, it has been demon-
strated that preincubation of the dsRNA in the Drosophila
Fig. 3. A. Block in haemoglobin hydrolysis in P. 
falciparum parasites after treatment with falci-
pain dsRNAs. Cultured parasites were incu-
bated for 48 h with: lane 1, water (control); lane 
2, dsRNAs from falcipains-1 and -2; lane 3, 
dsRNA from falcipain-1; lane 4, dsRNA from 
falcipain-2; lane 6, E64. Then, parasitized 
erythrocytes were lysed with saponin, and par-
asites were washed extensively to remove 
erythrocyte cytosolic components. Parasite pel-
lets were solubilized in reducing SDS-PAGE 
sample buffer, and parasite proteins were 
resolved on 10% SDS-PAGE. Haemoglobin 
protein was run as standard (lane 5), unde-
graded globin appeared as a dimer at ≈16 kDa. 
Lane M, molecular weight markers.
B. Northern blot analyses showing effects of 
falcipain dsRNA treatment on levels of endog-
enous RNA transcripts. Total RNA was 
extracted from control parasites (lane 1), ami-
nopeptidase dsRNA-treated parasites (lane 2), 
falcipain-1 dsRNA-treated parasites (lane 3) 
and falcipain-2 dsRNA-treated parasites (lane 
4) and separated on 1.2% agarose gel for 
Northern blotting. Blots were hybridized with 
random prime-labelled falcipain-1 DNA probe 
(i) and falcipain-2 DNA probe (ii).
1250 P. Malhotra et al.
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lysate results in potentiation of nuclease activity for target
mRNA degradation (Tuschl et al., 1999; Zamore et al.,
2000). To investigate whether similar specific activity was
generated in P. falciparum, cellular extracts from falcipain-
2 dsRNA-treated and untreated parasites were prepared
and incubated with 32P-labelled falcipain-2 mRNA in the
presence of ATP. Samples from these reaction mixtures
were taken at different time points and analysed by
agarose gel. As shown in Fig. 4B, extracts from dsRNA-
treated parasites efficiently degraded falcipain-2 tran-
script, whereas extracts from untreated parasites did not
degrade mRNA at all. Indeed, extracts from treated sam-
ples degraded mRNA very quickly, i.e. within 30 min of
incubation, most of the mRNA was degraded, whereas
extract from untreated parasites did not show any mRNA
degradation activity up to 3 h.
Discussion
The discovery of RNAi is one of the most exciting
advances in molecular genetics in recent years (Fire,
1999; Sharp, 2001). In the present study, we attempted
RNAi in P. falciparum, an intracellular parasite using dsR-
NAs from the two parasite-specific cysteine protease
genes (falcipain-1 and falcipain-2). We chose these genes
because the effects of different cysteine protease inhibi-
tors on the morphology and biochemistry of malaria
parasites, i.e. enlargement of the food vacuole with large
amounts of haemozoin in it and block in haemoglobin
degradation, have been well documented (Rosenthal,
1995; Rosenthal et al., 1996; Sijwali et al., 2001). Recom-
binant Falcipain proteins have also been shown to
degrade haemoglobin in vitro (Sijwali et al., 2001). More
recently, the role of cysteine proteases in the release of
malaria parasites from host erythrocytes has also been
postulated (Salmon et al., 2001). In the present investiga-
tion, the addition of each of the two falcipain dsRNAs to
P. falciparum culture resulted in inhibition of parasite
growth, development and enlargement of food vacuoles.
These effects were more pronounced when two falcipain
dsRNAs were put together. Moreover, each of the falcipain
dsRNAs produced a significant block in the degradation
of haemoglobin in the parasite. A non-specific dsRNA
from an aminopeptidase-N gene of insect origin did not
produce any of these effects. The additive effects pro-
duced by two falcipain dsRNAs suggested that haemoglo-
bin hydrolysis in parasites is probably a co-operative
process involving a number of different enzymes together.
The inhibitory effects produced by dsRNA treatment of
parasites coincided with a marked reduction in the levels
of endogenous mRNA homologous to the dsRNA in these
parasites, which is one of the hallmarks of RNAi. To con-
firm further that these effects resulted from falcipain dsR-
NAs, we simultaneously studied the uptake of labelled
falcipain dsRNAs by the malaria parasites. Indeed, we
observed the accumulation of radioactivity in the saponin-
lysed parasite pellets, suggesting uptake of dsRNA by the
parasites. Although we observed low levels of uptake of
radioactive falcipain dsRNAs compared with total input
counts, we believe that it is sufficient to produce RNAi.
DsRNA molecules do not seem to act stoichiometrically
to silence gene expression. In C. elegans, it has been
shown that two molecules of dsRNA per cell were able to
silence an abundantly expressed gene effectively (Fire
et al., 1998; Cogoni and Maino, 2000). We also compared
the effects produced by falcipain dsRNAs on malaria par-
asites with the effects of E-64, a well-known cysteine
Fig. 4. A. Generation of PTGS characteristic ≈ 25 nt RNA upon incu-
bation with falcipain dsRNAs in parasite culture. 32P-labelled dsRNA 
from each falcipain was added to P. falciparum cultures and incubated 
for 40 h. As a control, labelled dsRNAs were added to normal RBCs 
for the same period. Total RNAs were isolated from parasites, and 
small RNAs were purified from total RNA. The small RNA species 
were resolved on 15% denaturing acrylamide gel. Lane1, falcipain-1 
dsRNA-treated parasites; lane 2, falcipain-2 dsRNA-treated para-
sites; lane 3, control labelled dsRNA from falcipain-1; and lane 4, 
control labelled dsRNA from falcipain-2.
B. RNAi in vitro. Denaturing agarose gel analysis of radiolabelled 
falcipain-2 mRNA incubated for the times indicated with falcipain-2 
dsRNA-treated (i) and untreated parasite lysate (ii).
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protease inhibitor. Our study showed that various morpho-
logical as well as biochemical effects seen on malaria
parasites after treatment with falcipain dsRNAs were sim-
ilar to those shown by E-64. These results indicate that
RNAi can be an important tool in investigating metabolic
events in the parasite life cycle and add P. falciparum to
the list of organisms in which RNAi has been shown to
work successfully. Although substantial inhibitory effects
were observed with the highest concentrations of falci-
pains in the present study, we could never achieve 100%
efficacy. This could either be attributed to technical limits
of the RNAi application or suggest the existence of hidden
cysteine proteases in addition to the two taken up in the
present study.
The block in haemoglobin degradation observed by
silencing the activity of the falcipain genes in the present
study suggested that both the falcipain proteins are
required for initial cleavage of haemoglobin. Several dif-
ferent enzymes present in the food vacuole of P. falci-
parum appear to be involved in haemoglobin degradation,
but their precise role and hierarchy in the proteolysis of
haemoglobin are not clearly understood. It has been
suggested that haemoglobin degradation is an ordered
process with aspartic proteases leading the proteolytic
process, followed by cysteine and other proteases
(Goldberg et al., 1990). However, this model has been a
matter of debate, and results contrary to the above
hypothesis have been reported (Rosenthal, 1995; Shenai
et al., 2000). Taken together, the results of the present
study also suggest that cysteine proteases might be
involved in the initial cleavage of haemoglobin and that
their inhibition causes its accumulation in the parasite. In
this regard, our results support the work of Rosenthal
(1995), who showed that cysteine proteases are involved
right from the beginning in the proteolysis of haemoglobin.
It is quite possible that both classes of proteases are
playing a dominant role initially. However, regardless of
whether cysteine, aspartic or both classes of proteases
cleave haemoglobin initially inside the food vacuole, the
haemoglobin hydrolysis pathways remain an attractive tar-
get for the quest for new antimalarials.
Recently, on the basis of studies related to the RNAi
mechanism, a two-step RNA degradation process has
been proposed. The first step involves a dsRNA endonu-
clease [ribonuclease III (RNase III)]-like activity that pro-
cesses dsRNA into RNAs 21–25 nt long called siRNA. In
a second step, siRNAs produced in the first step serve as
a guide for a different ribonuclease complex, RISC (RNA-
induced silencing complex), which cleaves the homolo-
gous single-stranded mRNA (Metzke et al., 2001). We
wondered whether the mechanism of RNAi is similar in
P. falciparum. Analysis of small RNA species in the P.
falciparum culture treated with labelled falcipain dsRNAs
showed the generation of ≈ 25 nt labelled RNA species.
We also showed that parasite extracts prepared from
the P. falciparum culture treated with falcipain-2 dsRNA
have the ability to cleave falcipain-2 mRNA, whereas the
untreated parasite did not show this nuclease activity.
These results thus supported the two-step mechanism of
RNAi and also suggested a conservation of both mecha-
nisms and the components of dsRNA-induced gene
silencing in a diverse group of organisms. Recent genetic,
molecular and mutational studies have provided further
support for this hypothesis. Two sets of genes coding for
proteins implicated in RNAi have been identified in
different organisms. The first set of proteins is the one
with homology to tomato RNA-directed RNA polymerase
(RdRP): Neurospora QDE-1, C. elegans EGO-1 and
Araabidopsis SGS-2/SDE-1. The second set of proteins
involved in RNAi includes Arabidopsis AGO-1, Neuro-
spora QDE-2 and C. elegans RDE-1 (Fagard et al., 2000;
Elbashir et al., 2001; Grishok et al., 2001). A BLAST search
at the PlasmoDB.org site was carried out using tomato
RdRP and Arabidopsis AGO-1 sequences. A gene related
to AGO-1 was identified on chromosome 10 (19186) of P.
falciparum, which showed 31% identity to putative trans-
lation factor EIF-2B. We also found putative RNase III and
RdRP sequences in the P. falciparum genome, using
the Plasmodium genome BLASTX text query tool at the
PlasmoDB.org site, which showed some homology (29%
and 24% respectively) to that of Dictyostelium discoi-
deum. The significance of these findings remains to be
investigated.
The use of RNAi in P. falciparum to dissect gene func-
tions has several advantages over methods requiring the
introduction of DNA into cells. Transfection experiments
require knowledge of the full sequence of the gene and
its flanking regions, whereas for RNAi, dsRNA corre-
sponding to any gene fragments is sufficient to confer the
interference effect (Ullu and Tschudi, 2000). Moreover,
use of RNAi in P. falciparum as well as in other organisms
is technically simple and quick, and the result of protein
silencing can be obtained within 2–3 days. This contrasts
sharply with the time necessary to produce selective gene
‘knock-outs’ by transfection technology. RNAi in P. falci-
parum also provides a tool for studying the functions of a
number of genes together, as shown in the present study.
With the availability of a large amount of sequence infor-
mation for P. falciparum, RNAi-based functional genomics
can be a useful technique for investigating the biological
functions of novel genes. Finally, given the gene-specific
feature of RNAi and the ease of inducing RNAi, this
methodology may also play an important role in the
development of therapeutic applications against malaria.
In conclusion, the present study demonstrates that the
RNAi technique can be used conveniently for studying
1252 P. Malhotra et al.
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gene function in P. falciparum, and RNAi is mechanisti-
cally conserved in P. falciparum and other organisms.
Experimental procedures
RNA preparation
Individual DNA fragments coding for both falcipain-1 (1.7kb)
and falcipain-2 (1.4kb) genes (GenBank accession num-
bers AF239801 and M81341 respectively) (Fig. 1A) were
amplified by polymerase chain reaction (PCR) using P.
falciparum genomic DNA as a template and oligonucleotide
primer pairs Pf1(1) 5′-ATGGTTGCCATAAAAGAAATG-3′
and Pf1(2) 5′-TTACAAGATAGGATAGAAGAC-3′; and
Pf2(1) 5′-ATGGATTACAACATGGATTAT-3′ and Pf2(2) 5′-
TTATTCAATTAATGGAATGAA-3′. The PCR products were
gel purified and cloned into pGEM-T vector (Promega) to
generate pGFal-1 and pGFal-2 clones. The clones were
sequenced by dideoxy sequencing reactions and used as a
template to amplify individual falcipain genes using universal
and reverse primers (Promega). The PCR products were
purified using a PCR purification kit (Qiagen). The purified
PCR products were used as a template to generate sense
RNA (sRNA) and antisense RNA (asRNA) using T7 and SP6
RNA polymerases (Ambion). To make dsRNAs, equal
amounts of ssRNAs and asRNAs were mixed, heated to
65°C and annealed by slow cooling over several hours.
Individual RNAs and their dsRNAs were analysed on 1%
agarose gel. A 0.9 kb dsRNA from the unrelated aminopep-
tidase-N gene of insect Spodoptera litura was prepared in
a similar way to use as a control. To make 32P-labelled
dsRNAs, either sense or antisense strands of falcipain
genes were internally labelled using 0.3 µM [α-32P]-UTP
(3000 Ci mmol−1) and mixed with unlabelled complementary
strands. [32P]-dsRNAs were treated with RNase T1 to elimi-
nate ssRNA contaminants.
Parasite culture and RNAi
Plasmodium falciparum (strain 3D7) were cultured with
human erythrocytes with 5% haematocrit in RPMI media
(Gibco) supplemented with 10% human serum using a pro-
tocol described previously (Trager and Jensen., 1976). Par-
asite cultures were synchronized using sorbitol (Lambros and
Vanderber, 1979). For analysis of the effects of dsRNAs or
L-transepoxy-succinyl-leucylamido-(4-guanidino)-butane (E-
64), the synchronized cultures were adjusted to 5% haema-
tocrit with 1% infected red blood cells (RBCs), and 1 ml of
these cultures was treated in 24-well culture plates in tripli-
cate in serum-free medium for 30 min with intermittent
mixing. Subsequently, human serum was added to these
cultures to a final concentration of 10%, and parasites were
maintained further for 24 h or 48 h. For the microscopic anal-
ysis, smears were made from each well, stained with Giemsa
and examined for abnormalities as well as for the number
of ring-stage parasites. The number of ring-stage parasites
per 1500 RBCs was determined for each well. Parasites
with enlarged food vacuoles and haemozoin accumulation
were scored as abnormal. To assess the effects of various
dsRNAs/inhibitors on parasite metabolic activity, a [3H]-
hypoxanthine uptake assay was performed as described
previously (Rosenthal et al., 1996). Briefly, 100 µl of parasite
cultures (0.8–1.0% parasitaemia) at late ring stage were
incubated with dsRNAs in triplicate for 24 h, [3H]-hypoxan-
thine (Dupont-NEN) was added (1.2 µCi per well), and cul-
tures were maintained for an additional 24 h. Cultures of
mature parasites were frozen and thawed to lyse the
infected RBCs. Lysed cultures were harvested on glass-fibre
filters, which were subsequently washed with water, dried
with ethanol and counted on a scintillation counter. Uptake
of [3H]-hypoxanthine by dsRNA-treated parasites was com-
pared with that of control cultures treated with diethyl pyro-
carbonate (DEPC)-treated water.
Analysis of endogenous falcipain RNA transcripts
Northern blot analysis was carried out to determine the levels
of endogenous falcipain transcripts after falcipain dsRNA
treatment for 48 h. Total RNAs were prepared from treated
and untreated malaria parasites using the Qiagen RNA iso-
lation kit. Total RNA (1 µg) was fractionated on 1.2% agarose
gel, transferred to a nylon membrane (Hybond N+) and
hybridized with random prime-labelled falcipain-1 DNA probe
according to a previously described protocol (Kyes et al.,
2000). The blot was exposed to X-ray film (Kodak). After
exposure, the membrane was deprobed, hybridized with ran-
dom prime-labelled falcipain-2 DNA probe and re-exposed to
X-ray film.
Analysis of globin hydrolysis in P. falciparum parasites
To determine the effects of falcipain dsRNAs or E-64 on
haemoglobin degradation in the malaria parasite, P.
falciparum cultures were treated with these inhibitors for 24 h.
After the treatment, parasite-infected erythrocytes were
collected by centrifugation and lysed with 0.1% saponin in
PBS at 37°C for 15 min. The lysed samples were centrifuged,
and the parasite pellets were washed three times with ice-
cold PBS to remove erythrocyte cytoplasmic contents. The
washed parasite pellets were solubilized in SDS sample
buffer containing β-mercaptoethanol, boiled and separated
on 15% SDS-PAGE. The gels were stained with Coomassie
blue.
Analysis of falcipain dsRNA processing in P. falciparum
To determine whether falcipain dsRNAs inside P. falciparum
parasites are processed to small RNAs, as shown for RNAi
in the case of other organisms (Zamore et al., 2000), parasite
cultures were treated with 32P-labelled dsRNAs of falcipain-
1 and -2 separately as described earlier. Treated parasitized
erythrocytes were pelleted by centrifugation. Total RNAs
were extracted as described earlier. Low-molecular-weight
RNAs were extracted from total RNA by precipitation with 5%
polyethylene glycol−0.5 M NaCl (Hamilton and Baulcombe,
1999). Low-molecular-weight RNAs were subsequently anal-
ysed by electrophoresis through 15% polyacrylamide−7 M
urea−0.5% Tris-borate gel. The gel was dried under vacuum
and exposed to X-ray film (Kodak).
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Plasmodium falciparum extract preparations and 
degradation of mRNA in vitro
DsRNA-mediated gene silencing occurs as a result of acti-
vation of RNA-dependent nucleases inside the cells by
dsRNA. To show that similar activation is also responsible for
RNAi in P. falciparum, extracts were prepared from falcipain-
2 dsRNA-treated as well as DEPC water-treated parasites.
For the preparation of extracts, intact parasites were col-
lected by saponin lysis and washed three times in ice-cold
PBS to remove erythrocyte cytoplasmic components. The
washed parasite pellets were lysed by sonication in 200 µl of
lysis buffer [100 mM phosphate acetate, 30 mM HEPES-
KOH, 2 mM magnesium acetate and 5 mM dithiothreitol
(DTT), pH 7.4]. The lysate were centrifuged for 30 min at
15 000 g at 4°C, and the supernatants were flash frozen in
liquid nitrogen and stored at −80°C. The supernatants were
used for an in vitro assay. Typically, the reaction mixtures
(50 µl) contained 25 µl of parasite extract and 50 000 c.p.m.
of synthetic mRNA as a substrate in a buffer containing
20 mM HEPES, pH 7.3. 110 mM KOAc, 1 mM Mg (OAc)2,
3 mM EGTA, 2 mM CaCl2, 1 mM DTT and 1 mM ATP. The
reaction mixtures were incubated for different time periods at
37°C. Reactions were quenched by the addition of 10 vol-
umes of 2% PK buffer [200 mM Tris-HCl, pH 7.5, 25 mM
EDTA, 300 mM NaCl and 2% (w/v) SDS]. Proteinase K was
added to a final concentration of 465 µg ml−1. The reactions
were extracted with phenol–chloroform–isoamyl alcohol and
precipitated with an equal volume of isopropanol. Reactions
were analysed by electrophoresis in a formaldehyde–
agarose 0.8% gel. mRNA degradation was detected by
exposing the agarose gel dried under vacuum to X-ray film
(Kodak).
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